CELLPROTHERA

CellProthera is the first company having conducted successful proof of principle study with autologous CD34+ stem cells to repair myocardial tissue after acute myocardial infarct (AMI). The clinical outcome indicated an excellent safety profile associated with outstanding clinical benefits. The innovative approach developed by CellProthera is viewed by experts as one of the most effective to treat AMI and prevent secondary congestive heart failure (CHF).

#People #Financial #Website #More

CELLPROTHERA

Social Links:

Industry:

Biotechnology Health Care Medical

Founded:

2008-01-01

Address:

Mulhouse, Alsace, France

Country:

France

Website Url:

http://www.cellprothera.com

Total Employee:

11+

Status:

Active

Contact:

Total Funding:

8.4 M EUR

Technology used in webpage:

Euro IPv6 3 To 9 CcTLD Redirects

Current Employees Featured

matthieu-de-kalbermatten_image

Matthieu de KALBERMATTEN
Matthieu de KALBERMATTEN CEO @ CellProthera
CEO

philippe-hÉnon_image

Philippe HÉNON
Philippe HÉNON Chairman & CSO @ CellProthera
Chairman & CSO

georges-moussa_image

Georges Moussa
Georges Moussa Project Manager @ CellProthera
Project Manager
2018-07-01

jean-philippe-veillard_image

Jean-Philippe VEILLARD
Jean-Philippe VEILLARD CFO @ CellProthera
CFO

Founder

philippe-hÉnon_image

Philippe HÉNON

Investors List

alsace-business-angels_image

Alsace Business Angels

Alsace Business Angels investment in Seed Round - CellProthera

Official Site Inspections

http://www.cellprothera.com Semrush global rank: 7.49 M Semrush visits lastest month: 472

Host Informations
Whois Informations

Loading ...

More informations about "CellProthera" on Search Engine